Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Thrombosis
•
Pediatric Hematology
•
Anticoagulation
•
Pediatric Oncology
If a pediatric patient has a prior history of cancer-associated thrombosis while receiving active treatment, can they be on estrogen-containing OCPs in the future?
Related Questions
Do you recommend indefinite anticoagulation for patients with homozygous Factor V Leiden mutation who have had a provoked VTE?
What are your top takeaways from ISTH 2025?
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
How do you counsel an otherwise healthy patient on how soon they can go back to moderate exercise after a bilateral pulmonary embolism?
Do you use prophylactic defibrotide in pediatric patients undergoing BMT who are considered to be at high risk for the development of VOD/SOS?
How would you counsel a woman with a strong family history of thrombosis about oral contraceptives?
For which pediatric oncology patients do you start bacterial prophylaxis, inpatient or outpatient, and what is your antibiotic of choice?
How do you counsel patients with acute intermittent porphyria when it comes to fasting for religious reasons?
When would you consider genetic testing for G6PD deficiency diagnosis?
How will you treat an uterine embryonal rhabdomyosarcoma with regional node involvement resected to involved parametrial margins?
